Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

The questionnaire is valid and reliable but needs more testing for future predictions.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Baricitinib helps with early hair regrowth in people with alopecia areata.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

The laser treatment improved hair appearance and was safe and well-received by patients.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

Combining longxuejie and finasteride effectively reduces bleeding during TURP without side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Finasteride helps female-pattern hair loss.